International Patent: COMPOSITIONS TARGETING NEUROTENSIN RECEPTOR AND USES THEREOF

GENEVA, July 27 -- ALPHA-9 ONCOLOGY INC. filed a patent application (CA2026/050061) for “COMPOSITIONS TARGETING NEUROTENSIN RECEPTOR AND USES THEREOF”. With publication no. WO/2026/152218, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 401/14

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....